What are the prevention and treatment strategies for altitude sickness (Acute Mountain Sickness)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Altitude Sickness: Prevention and Treatment Strategies

The most effective prevention strategy for altitude sickness is a slow ascent rate (less than 400 m/day above 2500m), combined with prophylactic acetazolamide (125-250 mg twice daily) starting 24 hours before ascent for those at higher risk. 1

Understanding Altitude Sickness

Altitude sickness, also known as Acute Mountain Sickness (AMS), occurs when individuals ascend too rapidly to high altitudes without proper acclimatization. It encompasses several conditions:

  • Acute Mountain Sickness (AMS): Milder form with symptoms including headache, nausea, dizziness, fatigue, and insomnia
  • High-Altitude Cerebral Edema (HACE): Severe progression of AMS with symptoms of severe headache, ataxia, and mental deterioration
  • High-Altitude Pulmonary Edema (HAPE): Characterized by extreme fatigue, dyspnea, chest tightness, and potentially pink frothy sputum

Risk Factors

  • Rapid ascent: Ascending faster than 300-600 m/day above 2500m 1, 2
  • Gender: Women appear to have a higher risk of AMS 3, 1
  • Previous history: Prior episodes of altitude sickness increase risk
  • Physical condition: Poor physical fitness may increase risk
  • Underlying conditions: Heart failure, anemia, and respiratory conditions increase susceptibility 3
  • Menstrual cycle phase: Women may have better oxygenation during the luteal phase 3

Prevention Strategies

Non-Pharmacological Approaches

  1. Gradual ascent:

    • Limit ascent to less than 400 m/day above 2500m 3, 1
    • Include a rest day for every 600-1200m gained 1
  2. Pre-acclimatization:

    • For those with access to altitude facilities, 2 weeks with >8 hours/day at progressively increasing altitudes is beneficial 3
    • Particularly important for women due to higher AMS risk 3, 1
  3. Adequate hydration and nutrition:

    • Maintain proper hydration
    • Women may require less increase in carbohydrate intake at altitude compared to men 3
  4. Iron supplementation:

    • Consider for women before altitude exposure due to higher risk of iron deficiency 1

Pharmacological Prevention

  1. Acetazolamide:

    • Dosage: 125-250 mg twice daily starting 24 hours before ascent 1
    • Mechanism: Increases ventilation and oxygenation by creating a mild metabolic acidosis
    • Contraindications: Kidney stones, sulfa allergy, severe hepatic/renal disease 1
    • Side effects: Paresthesias, altered taste, increased urination, dizziness 1
  2. Dexamethasone:

    • Alternative for those who cannot take acetazolamide
    • 4 mg every 6 hours starting 48 hours before ascent 4
    • More effective for cerebral symptoms than respiratory symptoms
  3. Nifedipine:

    • 20 mg extended-release every 8 hours for HAPE prevention 1
    • Particularly useful for those with previous HAPE episodes

Treatment Strategies

Mild to Moderate AMS

  1. Stop ascent and rest:

    • Allow time for acclimatization
    • Avoid further ascent until symptoms resolve
  2. Medication:

    • Acetazolamide: 250 mg twice daily 1, 2
    • Ibuprofen for headache 5
    • Avoid sedatives and alcohol
  3. Oxygen supplementation:

    • If available, maintain oxygen saturation >90% 1

Severe AMS, HACE, or HAPE

  1. Immediate descent:

    • Most effective treatment
    • Descend at least 300-600m as soon as possible 1, 6
  2. Oxygen therapy:

    • Administer supplemental oxygen to maintain saturation >90% 1
  3. Medication:

    • For HACE: Dexamethasone (8 mg initially, then 4 mg every 6 hours)
    • For HAPE: Nifedipine (10 mg initially, then 30 mg extended-release every 12-24 hours)
  4. Hyperbaric therapy:

    • Portable hyperbaric chambers can be used when descent is not possible

Special Considerations

  1. Heart failure patients:

    • Travel to intermediate altitudes (~2000m) is generally safe for those with good exercise tolerance at sea level 3
    • Diuretic therapy should be tailored to account for hypoxic diuresis 3
  2. Women travelers:

    • Consider timing high altitude exposure during mid-luteal phase when hypoxic ventilatory response is higher 3
    • Perform hypoxic tolerance tests in follicular phase to assess risk 3
  3. Post-ocular surgery:

    • Avoid air travel for 2-6 weeks after intraocular gas instillation 3

Monitoring and Follow-up

  • Monitor for progression of symptoms
  • Check for signs of HACE (ataxia, altered mental status)
  • Monitor oxygen saturation if possible
  • For those on acetazolamide, monitor for electrolyte imbalances and metabolic acidosis 1

By following these prevention and treatment strategies, the risk and severity of altitude sickness can be significantly reduced, allowing for safer travel to high-altitude destinations.

References

Guideline

High Altitude Sickness Prevention and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Mountaineering and altitude sickness].

Therapeutische Umschau. Revue therapeutique, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prevention of acute mountain sickness by dexamethasone.

The New England journal of medicine, 1984

Research

Acute mountain sickness: pathophysiology, prevention, and treatment.

Progress in cardiovascular diseases, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.